A Case Report of Chronic Allergic Rhinitis Treatment in A 29-Year-Old Woman Based on Iranian Traditional Medicine

Document Type : Case reports or series

Authors

1 Assistant Professor, Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 MD, PhD in Persian Medicine, Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Introduction: Allergic rhinitis is one of the most commonly diagnosed allergic diseases, the prevalence of which is increasing globally. The purpose of this case report is to outline the Iranian traditional medicine (ITM) approach to diagnosis and treatment of chronic allergic rhinitis.
Case presentation: A 29-year-old woman with a long history of symptoms of runny nose, sneezing and itchy throat was diagnosed with seasonal allergic rhinitis and treated with antihistamines. Since 9 years ago, the disease pattern changed from seasonal to a year-round state and the patient referred to the traditional medicine clinic due to inadequate response to conventional therapies and reluctance to consume oral corticosteroids. Initially, the six lifestyle essentials and prohibited foods were explained to the patient, followed by drug therapy to cleanse the head region and body and to eliminate the underlying causes of the disease. The post45-day treatment assessment showed a significant reduction in the severity and frequency of symptoms.
Conclusion: Clinical decision-making in ITM is based on a holistic view of the patient rather than the disease, which is the case in conventional medicine. This case report is an example of a patient-based treatment protocol in the Iranian medical system. The systemic approach of ITM in dealing with a patient with allergic rhinitis and simultaneous attention to brain and whole-body cleansing along with the six essentials of lifestyle modification resulted in significant improvement.

Keywords

References

1.Berrettini S, Carabelli A, Sellari‐Franceschini S, Bruschini L, Quartieri F, Sconosciuto F, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy. 1999;54(3):242-8.
2.Rondón C, Campo P, Togias A, Fokkens WJ, Durham SR, Powe DG, et al. Local allergic rhinitis: Concept, pathophysiology, and management. Journal of allergy and clinical immunology. 2012;129(6):1460-7.
3.Mims JW. Epidemiology of allergic rhinitis. International Forum of Allergy & Rhinology. 2014;4(S2):S18-S20.
4.Torres-Borrego J, Molina-Teran A, Montes-Mendoza C. Prevalence and associated factors of allergic rhinitis and atopic dermatitis in children. Allergologia et immunopathologia. 2008;36(2):90-100.
5.Bellanti JA, Wallerstedt DB, editors. Allergic rhinitis update: epidemiology and natural history. Allergy and Asthma Proceedings; 2000: OceanSide Publications, Inc.
6.Bousquet J, Annesi‐Maesano I, Carat F, Leger D, Rugina M, Pribil C, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clinical & Experimental Allergy. 2005;35(6):728-32.
7.Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. Journal of allergy and clinical immunology. 2001;108(1):S2-S8.
8.Bielory L, Chun Y, Bielory B, Canonica G. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta‐analysis. Allergy. 2011;66(5):686-93.
9.Spector SL. Overview of comorbid associations of allergic rhinitis. Journal of allergy and clinical immunology. 1997;99(2):S773-S80.
10.Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. International immunopharmacology. 2011;11(11):1646-62.
11.Colás C, Galera H, Anibarro B, Soler R, Navarro A, Jáuregui I, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clinical & Experimental Allergy. 2012;42(7):1080-7.
12.Lack G. Pediatric allergic rhinitis and comorbid disorders. Journal of Allergy and Clinical Immunology. 2001;108(1, Supplement):S9-S15.
13.Camelo-Nunes IC, Solé D. Allergic rhinitis: indicators of quality of life. Jornal Brasileiro de Pneumologia. 2010;36(1):124-33.
14.Schoenwetter WF, Dupclay L, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-of-life burden of allergic rhinitis. Current medical research and opinion. 2004;20(3):305-17.
15.Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6(3):373-8.
16.Blaiss MS, editor. Allergic rhinitis: Direct and indirect costs. Allergy and Asthma Proceedings; 2010: OceanSide Publications, Inc.
17.Lamb CE, Ratner PH, Johnson CE, Ambegaonkar AJ, Joshi AV, Day D, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Current medical research and opinion. 2006;22(6):1203-10.
18.Bhattacharyya N. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States. The Laryngoscope. 2011;121(9):1830-3.
19.Sharif M. Zadolmosaferin. 1st ed. Jalaleddin; Qom, Iran: 2008.
20.Jurjani SI. Zakhireh-i Kharazmshahi, Photo Offset from the Original Hand Written Manuscript. Edited by Saeedi Sirjani. Tehran: Iran Cultural Publications; 1976. [In Persian].
21.Exire-Azam ACM. Tehran. Iran: Nasle Nikan. 2008.
22.Scadding G, Durham S, Mirakian R, Jones N, Leech S, Farooque S, et al. BSACI guidelines for the management of allergic and non‐allergic rhinitis. Clinical & Experimental Allergy. 2008;38(1):19-42.
23.Shah-Arzani M. Tib-e-Akbari. Ghom: Jalal-ed-Din. 2008.

Files

Share

How to cite

Statistics